Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Hunninghake

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
The American Journal of Cardiology|January 4, 2001
Lessons from the post coronary artery bypass graft study in evaluating and controlling technical variability in angiographic trials. Post CABG InvestigatorsC W White, L Campeau, P Canner, et al.
Annals of Internal Medicine|November 1, 1987
Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter studyR J Havel, D B Hunninghake, D R Illingworth, et al.
Journal of Thrombosis and Thrombolysis|June 15, 2001
The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatmentJ M Walenga, D Hoppensteadt, R Pifarré, et al.
Circulation|June 29, 1999
Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial InvestigatorsL Campeau, D B Hunninghake, G L Knatterud, et al.
American Heart Journal|October 31, 2000
Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial diseaseR Garg, M B Elam, J R Crouse, et al.
Current Medical Research and Opinion|July 24, 2001
A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trialD R Illingworth, J R Crouse, D B Hunninghake, et al.
Circulation|July 13, 2000
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG InvestigatorsG L Knatterud, Y Rosenberg, L Campeau, et al.
Circulation|November 28, 2001
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trialC W White, F L Gobel, L Campeau, et al.
Pharmacoeconomics|June 6, 1998
The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatinM J Koren, D G Smith, D B Hunninghake, et al.
JAMA|September 19, 2001
Peripheral arterial disease detection, awareness, and treatment in primary careA T Hirsch, M H Criqui, D Treat-Jacobson, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
The American Journal of Cardiology|January 4, 2001
Lessons from the post coronary artery bypass graft study in evaluating and controlling technical variability in angiographic trials. Post CABG InvestigatorsC W White, L Campeau, P Canner, et al.
Annals of Internal Medicine|November 1, 1987
Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter studyR J Havel, D B Hunninghake, D R Illingworth, et al.
Journal of Thrombosis and Thrombolysis|June 15, 2001
The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatmentJ M Walenga, D Hoppensteadt, R Pifarré, et al.
Circulation|June 29, 1999
Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial InvestigatorsL Campeau, D B Hunninghake, G L Knatterud, et al.
American Heart Journal|October 31, 2000
Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial diseaseR Garg, M B Elam, J R Crouse, et al.
Current Medical Research and Opinion|July 24, 2001
A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trialD R Illingworth, J R Crouse, D B Hunninghake, et al.
Circulation|July 13, 2000
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG InvestigatorsG L Knatterud, Y Rosenberg, L Campeau, et al.
Circulation|November 28, 2001
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trialC W White, F L Gobel, L Campeau, et al.
Pharmacoeconomics|June 6, 1998
The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatinM J Koren, D G Smith, D B Hunninghake, et al.
JAMA|September 19, 2001
Peripheral arterial disease detection, awareness, and treatment in primary careA T Hirsch, M H Criqui, D Treat-Jacobson, et al.
Pageof 12